52 related articles for article (PubMed ID: 2484336)
1. [Update on a titration method for measuring the interferon-producing capacity in humans].
Kita M; Yamaji M; Kishida T; Imanishi J
C R Seances Soc Biol Fil; 1989; 183(6):578-83. PubMed ID: 2484336
[TBL] [Abstract][Full Text] [Related]
2. [Interferon-producing capacity in patients with prostate cancer: prognosis value].
Kita M; Nakagawa S; Watanabe H; Kitoh I; Yamaji M; Kishida T; Imanishi J
C R Seances Soc Biol Fil; 1990; 184(2):181-6. PubMed ID: 2148903
[TBL] [Abstract][Full Text] [Related]
3. [Time course of interferon status of patients with herpetic keratitis during treatment with actipol, a new inteferon inducer].
Akberova SI; Ershov FI; Musaev Galbinur PI; Tazulakhova EB; Mamedova VM
Vestn Oftalmol; 2001; 117(1):33-6. PubMed ID: 11339038
[TBL] [Abstract][Full Text] [Related]
4. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
[TBL] [Abstract][Full Text] [Related]
5. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.
Hishizawa M; Imada K; Kitawaki T; Ueda M; Kadowaki N; Uchiyama T
Br J Haematol; 2004 Jun; 125(5):568-75. PubMed ID: 15147371
[TBL] [Abstract][Full Text] [Related]
6. The capacity of blood lymphoid cells to produce alpha- and gamma-interferon is decreased during alpha-interferon therapy.
Einhorn S; Ling P; Einhorn N; Strander H
J Clin Lab Immunol; 1987 May; 23(1):35-8. PubMed ID: 3112404
[TBL] [Abstract][Full Text] [Related]
7. Detection of interferon inhibitors or antagonists in gastrointestinal malignancies.
Karmaniolas KD; Papalampros TS; Papavassiliou ED; Liatis STh ; Kalantzis N
Hepatogastroenterology; 1998; 45(24):2244-7. PubMed ID: 9951903
[TBL] [Abstract][Full Text] [Related]
8. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells.
Wichmann G; Herbarth O; Lehmann I
Environ Toxicol; 2002; 17(3):211-8. PubMed ID: 12112629
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
10. The IFN-alpha-inducing capacity of Sendai Virus in human leukocytes is independent from the hemagglutinating and hemolytic activities and from the viral proteins of the Sendai Virus preparations.
Mattana P; Scapol L; Silvestri S; Viscomi GC
J Biol Regul Homeost Agents; 1999; 13(4):201-6. PubMed ID: 10703943
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
13. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
14. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
Orzechowska B; Antoszków Z; Błach-Olszewska Z
Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
[TBL] [Abstract][Full Text] [Related]
15. Interferon and tumor necrosis factor responses of HIV+ patients as markers for monitoring of the AIDS progression.
Piasecki E; Ledwoń TK; Inglot AD; Knysz B; Simon K; Inglot M; Gładysz A
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):439-45. PubMed ID: 8572904
[TBL] [Abstract][Full Text] [Related]
16. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation.
Payvandi F; Amrute S; Fitzgerald-Bocarsly P
J Immunol; 1998 Jun; 160(12):5861-8. PubMed ID: 9637497
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass.
Flohé S; Börgermann J; Lim L; Schade FU
J Endotoxin Res; 2000; 6(6):431-6. PubMed ID: 11521067
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
19. Interferon producing capacity (IPCA) of peripheral mononuclear cell in oral cancer patients.
Jamkar AV; Banerjae AC; Gore MM; Sathe PS; Ghosh SN
Indian J Cancer; 1989 Jun; 26(2):76-84. PubMed ID: 2512248
[TBL] [Abstract][Full Text] [Related]
20. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
